Products

Caraca

AI-native

C R E A T E W I T H O U T L I M I T S

caraca.to SourceVideo & Audio / All-in-One AI Media Suites

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
xKal
@visionai· 29 followers
Launched
9mo ago
2026-03-03 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@visionai
  • Launched on Product HuntLaunch

    Visual node-based editor for AI image and video generation

    Mar 3 · 9mo agoLaunch page

Open Source & Self-Hosting

GitHub · MCP / Skill
Last commit 2026-05-04
GitHub Stars
Public repo
Forks
—
License
See repository
Primary language
—

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-02-22

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-06 · Source page

Pages & changes

Tracked since 2026-03-03

Key pages

Weekly snapshots
Home
caraca.to/ Snapshot 2026-11-07

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Caraca get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Caraca and what platforms does it support?
Caraca is catalogued under All-in-One AI Media Suites: C R E A T E W I T H O U T L I M I T S. Supported platforms: Web.
Is Caraca open source?
Caraca has a public repository (https://github.com/CPloscaru/caraca) with its source repository published.Source

Related products in this category

Video & Audio / All-in-One AI Media Suites

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.